AI Integration and SPAC Merger: Cellularity CEO Discusses Advances in Cancer Treatment and Lessons from the Pandemic| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc. 00:10:00

Share On Facebook Share On Twitter

The CEO of a clinical stage biotech company discusses the integration of artificial intelligence in cancer treatments and the company's upcoming SPAC merger, highlighting potential advancements and lessons from the pandemic in the field of cellular medicine.

Recent Videos